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Burkholderia thailandensis. Furthermore, mice deficient in IRF8 were impaired in their ability to produce
IL-18 and suffered higher bacterial burdens. Altogether, our data highlights the role of IRF8 as a
transcriptional regulator of NAIPs for NLRC4 inflammasome activation.
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ABSTRACT
The NLRC4 inflammasome is a crucial part of the innate immune response
against bacterial infections. We found that NLRC4 inflammasome activation in bone
marrow-derived macrophages (BMDMs) is greatly dependent on interferon regulatory
factor 8 (IRF8). NLRC4-mediated caspase-1 activation and subsequent production of the
inflammasome-dependent cytokines IL-1ȕ and IL-18 and cell death were impaired in
IRF8-deficient cells. IRF8 mediated the transcription of genes encoding NAIPs, the
receptors for NLRC4 inflammasome, which recognize bacterial flagellin and type III
secretion system (T3SS) proteins. IRF8 was critical for host survival following infection
with Salmonella Typhimurium or Burkholderia thailandensis. Furthermore, mice
deficient in IRF8 were impaired in their ability to produce IL-18 and suffered higher
bacterial burdens. Altogether, our data highlights the role of IRF8 as a transcriptional
regulator of NAIPs for NLRC4 inflammasome activation.
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CHAPTER 1.

INTRODUCTION

Background
Inflammasomes
Inflammasomes are multimeric protein complexes that cleave pro-caspase-1 into
its active form in response to certain pathogen-associated molecular patterns (PAMPs)
and danger-associated molecular patterns (DAMPs). The inflammasome complex
comprises the sensor, adaptor, and enzyme. Members of nucleotide-binding
oligomerization domain and leucine-rich repeat receptors (NLRs), absent in melanoma-2
(AIM2)-like receptors (ALRs), and pyrin serve as sensors. These proteins have caspase
activation and recruitment domain (CARD) or pyrin domain (PYD) for homotypic
interactions. ASC, which contains both CARD and PYD, functions as an adaptor for
oligomerization of the complex. Inflammasome activation has two major consequences.
Active caspase-1 processes the pro-inflammatory cytokines IL-ȕDQG,/-18 into their
mature forms for extracellular release 1. Also, caspase-1 cleaves gasdermin D which
forms pores in the plasma membrane to induce a form of inflammatory cell death termed
pyroptosis 2–4 .
NLRC4 (IPAF) was first identified in 2001 to interact with and activate caspase1 . It was found that cytosolic flagellin derived from bacteria activated caspase-1 through
NLRC4 6,7. Because NLRC4 has a CARD capable of direct interaction with caspase-1,
ASC is not required for NLRC4 inflammasome assembly and downstream cell death.
However, production of cytokines by the NLRC4 inflamamsome is dependent on ASC 8,9.
The NLRC4 inflammasome is important for host defense against intracellular pathogens
such as Salmonella 10,11.
5

Although NLR family apoptosis inhibitory proteins (NAIPs) were previously
discovered, the connection between NLRC4 and NAIPs was not identified until it was
suggested that NAIP5 (BIRC1E) might trigger inflammasome assembly 12. Now NAIPs
are fully recognized as the direct receptors for bacterial protein recognition in the NLRC4
inflammasome 13. NAIP1 detects bacterial type III secretion system (T3SS) needle and
NAIP2 detects T3SS rod, while flagellin is sensed by NAIP5 and NAIP6 14–17. Humans
have a single NAIP which is reported to interact with all three types of bacterial
proteins18–20. It is not known how NAIPs or NLRC4 inflammasome activation may be
regulated for cellular immunity.
Interferon Signaling in Inflammasome Activation
Interferon (IFN) signaling is known to play a pivotal role in inflammasome
activation during microbial infection. Type I IFNs are indispensable for non-canonical
activation of the NLRP3 inflammasome in response to Gram-negative bacteria. IFN-Įȕ
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receptor (IFNAR) signaling involves in upregulation of caspase-11 and is essential for its
processing 21,22. AIM2 inflammasome activation in response to Francisella is also
dependent on type I IFNs 23,24. Interferon regulatory factors (IRFs) are a central part of
IFN signaling as they regulate the transcription of IFNs and IFN–inducible genes 25. IRF1
is required for the induction of guanylate-binding proteins (GBPs) that liberate
Francisella double-stranded DNA (dsDNA) into the cytosol, allowing AIM2
inflammasome activation 26 (Figure 1-1).
IRF8 is an IRF family member previously known as IFN consensus sequence
binding protein (ICSBP), which interacts with IRF1 27. Both factors are basally expressed
in macrophages and further inducible by IFNs and lipopolysaccharide (LPS) 28–31.
Transcription of IL-12 and iNOS is cooperatively promoted by IRF1 and IRF8 32–35.
Chromatin immunoprecipitation-sequencing (ChIP-seq) in bone marrow-derived
macrophages (BMDMs) shows that IRF1 and IRF8 are co-recruited together at more than
4000 genomic regions after IFN-ȖWUHDWPHQW 36. Although IRF8 is known to widely
participate in antimicrobial defense, its role in inflammasomes is unknown.
Hypothesis
IRF1 is required for AIM2 inflammasome activation in response to Francisella
infection, and multiple studies have shown functional interaction of IRF1 and IRF8 in
mediating pathogen clearance. Thus, it is proposed that IRF8 may be required for
promoting inflammasome activation during bacterial infection.

2

Figure 1-1. IFN signaling in inflammasome activation
Type I IFNs are produced in response to infection with Gram-negative bacteria, and
signaling through IFNAR is required for caspase-11-dependent NLRP3 inflammasome
activation. Cellular recognition of Francisella is dependent on type I IFN signaling and
IRF1 for the transcription of GBPs. GBP2 and GBP5 localize to the bacterial wall of
Francisella, releasing dsDNA which is recognized by the AIM2 inflammasome.
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CHAPTER 2.

MATERIALS AND METHODS 1
Experimental Models

Mice
Irf8–/– mice (Jackson Laboratory, 018298), Irf1–/– mice 37, Nlrp3–/– mice 38, Nlrc4–
/–
mice 6, Nlrp3–/–Nlrc4–/– mice (generated by crossing Nlrp3–/– and Nlrc4–/– mice in our
facility), Aim2–/– mice 39 , Pyrin–/– mice 40, and Naip5–/– mice 41 (kindly provided by Dr. R.
Vance), Il18–/–Il1r–/– mice (generated by crossing Il18–/– and Il1r –/– mice in our facility),
Gsdmd–/– mice (generated in our facility), Casp1–/– mice 42, Casp11–/– mice 43, Irf3–/–
mice44, Irf7–/– mice 45, Irf3–/– Irf7–/– mice (generated by crossing Irf3–/– and Irf7 –/– mice in
our facility), Irf9–/– mice 46, Ifnar1–/– mice 47, Ifnar2–/– mice 48, Stat1–/– mice 37, Trif–/–
mice 49, Mavs1–/– mice 50, Ifih1–/– (Mda5–/–) mice 51, Mb21d1–/– (Cgas–/–) mice 52, and
Tmem173–/– (Stinggt/gt) mice 53 have been described. All mice were bred at St. Jude
Children’s Research Hospital. Animal studies were conducted under protocols approved
by St. Jude Children’s Research Hospital’s committee on the use and care of animals.
Bone Marrow-Derived Macrophages (BMDMs)
Primary BMDMs were grown for 6 days in DMEM (ThermoFisher Scientific,
11995-073) supplemented with 1% non-essential amino acids (ThermoFisher Scientific,
11140-050), 10% FBS (Biowest, S1620), 30% medium conditioned by L929 mouse
fibroblasts, and 1% penicillin and streptomycin (ThermoFisher Scientific, 15070-063).
BMDMs in antibiotic-free medium were seeded onto 12-well plates at a density of 106
cells per well, followed by incubation overnight.
Bacterial Culture
Francisella novicida strain U112 was grown overnight under aerobic conditions
at 37°C in BBL Trypticase Soy Broth (BD Biosciences, 211768) supplemented with 0.2%
L-cysteine (ThermoFisher Scientific, BP376-100). Bacteria were subcultured (1:10) for 4
h at 37°C in fresh Trypticase Soy Broth supplemented with 0.2% L-cysteine and
resuspended in PBS (ThermoFisher Scientific, 14190-250). Salmonella Typhimurium
strain SL1344, isogenic mutants lacking SPI-1 ǻSPI-1), isogenic mutants lacking SPI-2
ǻSPI-2), isogenic mutants lacking fliC and fljB ǻfliCǻfljB), Burkholderia thailandensis
strain E264 (a gift from Dr. Joseph Mougous), and Pseudomonas aeruginosa strain
PAO1 (a gift from Dr. Joseph Mougous) were inoculated into Luria-Bertani (LB) broth
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Modified from final submission with permission. Karki R*, Lee E*, Place D, Samir P, Mavuluri J,
Sharma BR, et al. IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. Cell. 2018
May 3;173(4):920-933.e13. (*Co-first author). https://doi.org/10.1016/j.cell.2018.02.055 [76].
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(MP Biomedicals, 3002-031) and incubated overnight under aerobic conditions at 37°C.
S. Typhimurium SL1344, all isogenic mutants of S. Typhimurium SL1344, B.
thailandensis strain E264, and P. aeruginosa strain PAO1 were subcultured (1:10) for 3 h
at 37°C in fresh LB broth to generate bacteria grown to log phase. Clostridium difficile
VWUDLQU$%íDQG$%VWUDLQVZHUHSURYLGHGE\'U10LQWRQ54. Strains were
streaked onto brain heart infusion agar (BD Biosciences, 211065) and incubated
overnight at 37°C in an anaerobic chamber. Single colonies were inoculated into
tryptone-yeast extract medium and grown overnight at 37°C anaerobically. C. difficile
cultures for cell stimulation were prepared by collecting supernatant via centrifugation
followed by sterilization through a 0.2 μm filter.
Methods
Stimulation of BMDMs
Ligands
For activation of the canonical NLRP3 inflammasome, BMDMs were primed for
4 h with 100 ng/mL ultrapure LPS from Salmonella minnesota R595 (InvivoGen, tlrlsmlps) and were stimulated for 45 min with 5 mM ATP (Roche, 10127531001). For
transfection of DNA, each reaction consisted of 2 μg of poly(dA:dT) (InvivoGen, tlrlpatn) resuspended in PBS and mixed with 0.6 μL of Xfect polymer in Xfect reaction
buffer (Clontech Laboratories, Inc, 631318). After 10 min, DNA complexes were added
to BMDMs in Opti-MEM (ThermoFisher Scientific, 31985-070), followed by incubation
for 5 h. For IRF8 expression, BMDMs were stimulated with 100 ng/mL ultrapure LPS for
indicated times. For bacterial protein transfection, 0.1 μg, 0.5 μg, or 1 μg of ultrapure
flagellin from Salmonella Typhimurium (InvivoGen, tlrl-epstfla-5); 1 μg of recombinant
Salmonella Typhimurium PrgI (Mybiosource, MBS1177087); and 1 μg of recombinant
Salmonella Typhimurium PrgJ (Mybiosource, MBS2061410) were resuspended in PBS
and mixed with 20 μL of DOTAP (Roche, 11202375001) per reaction. The reaction
mixture was incubated for 1 h and added to BMDMs in 500 μL Opti-MEM.
Bacterial infections
For bacterial infection, the following conditions were used: F. novicida at an MOI
of 100 for 20 h of incubation (for activation of caspase-1) and an MOI of 50 for 2, 8, 16,
or 24 h of incubation (for expression of IRF8, GBP2, and GBP5); S. Typhimurium at an
MOI of 0.01, 0.1, or 1 for 4 h of incubation (for activation of caspase-1) and an MOI of
IRULQGLFDWHGWLPHV IRUH[SUHVVLRQRI,5) ǻSPI-1 at an MOI of 1 for 4 h of
LQFXEDWLRQǻSPI-2 DWDQ02,RIIRUKRILQFXEDWLRQǻfliCǻfljB at an MOI of 1 for 4
h of incubation; B. thailandensis at an MOI of 0.5, 1, or 5 for 4 h of incubation (for
activation of caspase-1) and an MOI of 1 for indicated times (for expression of IRF8);
and P. aeruginosa at an MOI of 0.5, 1, or 5 for 4 h of incubation. 50 μg/ml gentamicin
(ThermoFisher Scientific, 15750-060) was added after 8 h (F. novicida) post-infection to
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kill extracellular bacteria. Cell culture supernatants were collected for enzyme-linked
immunosorbent assays (ELISAs). Levels of lactate dehydrogenase released by cells were
measured by performing a CytoTox 96 non-radioactive cytotoxicity assay according to
the manufacturer’s instructions (Promega, G1780).
Small Interfering RNA (siRNA) Knockdown
BMDMs were transfected for 48 h with siRNA from siGENOME smart pools by
using the GenMute siRNA Transfection Reagent according to the manufacturer’s
instructions (SignaGen Laboratories, SL100568). The siGENOME SMARTpool siRNA
specific for mouse Irf8 (Dharmacon, M-040737-00) was used in the study. A control
siRNA pool was also used. Transfected cells were infected with S. Typhimurium as
described above.
Immunoblot Analysis
BMDM cell lysates and culture supernatants were combined in caspase lysis
buffer (containing protease inhibitors, phosphatase inhibitors, 10% NP-40, and 25mM
DTT) and sample loading buffer (containing SDS and 2-mercaptoethanol) for
immunoblot analysis of caspase-1. For immunoblot analysis of signaling, supernatants
were removed and BMDMs were washed once with PBS, followed by lysis in RIPA
buffer and sample loading buffer (containing SDS and 2-Mercaptoethanol). Proteins were
separated by electrophoresis through 8-12% polyacrylamide gels. Following
electrophoretic transfer of proteins onto PVDF membranes (Millipore, IPVH00010),
nonspecific binding was blocked by incubation with 5% skim milk, then membranes
were incubated with primary antibodies anti-caspase-1 (1:3,000 dilution; Adipogen, AG20B-0042), anti-IRF8 (1:1,000 dilution; Santa Cruz Biotechnology, sc-6058), anti-GBP2
(1:1,000 dilution; Proteintech, 11854-1-AP), anti-GBP5 (1:1,000 dilution; Proteintech,
13220-1-AP), or anti- ȕ-actin (1:10,000 dilution; Proteintech, 66009-1-IG). Membranes
were then washed and incubated with the appropriate horseradish peroxidase (HRP)conjugated secondary antibodies (1:5,000 dilution; Jackson Immuno Research
Laboratories, anti-rabbit [111-035-047], anti-mouse [315-035-047], and anti-goat [705035-003]) for 1 h. Proteins were visualized by using Luminata Forte Western HRP
Substrate (Millipore, WBLUF0500).
Real-Time PCR (RT-PCR) Analysis
For bacterial stimulation, the following conditions were used: S. Typhimurium at
an MOI of 0.01; and for flagellin transfection, 0.1 μg of flagellin. RNA was extracted by
using TRIzol (ThermoFisher Scientific, 15596026) according to the manufacturer’s
instructions. The isolated RNA was reverse-transcribed into cDNA by using a FirstStrand cDNA Synthesis Kit (Applied Biosystems, 4368814). RT-PCR was performed on
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an ABI 7500 RT-PCR instrument by using 2X SYBR Green (Applied Biosystems,
4368706) and the appropriate primers (Table 2-1).
Cytokine Analysis
Cytokines were measured by performing multiplex ELISA (Millipore,
MCYTOMAG-70K) or ELISA for IL-18 (Invitrogen, BMS618-3) according to the
manufacturer’s instructions.
Flow Cytometry
The following monoclonal antibodies were used for flow cytometry cellular
analyses: CD11b (M1/70; Affymetrix eBioscience, 48-0112-82) and F4/80 (BM8;
BioLegend, 123109). The dilution factor used for these antibodies was 1:300. Flow
cytometry data were acquired on a FACSCalibur flow cytometer (BD) and were analyzed
by using FlowJo software (FlowJo, LLC and Illumina, Inc).
Microarray
Transcripts were profiled for S. Typhimurium-infected BMDMs obtained from
WT and Irf8–/– mice. Total RNA (100 ng) was converted into biotin-labeled cRNA by
using an Ambion Wild-Type Expression kit (ThermoFisher Scientific, 4411973) and was
hybridized to a Affymetrix GeneChip Mouse Gene 2.0 ST Array (ThermoFisher
Scientific, 902119). After chips were stained and washed, array signals were normalized
and transformed into log2 transcript expression values by using the robust multi-array
average algorithm (Partek Genomics Suite version 6.6). Differential expression was
defined by application of a difference in expression of 0.5-fold (log2 signal) between
conditions. Lists of differentially expressed transcripts were analyzed for ‘functional
enrichment’ by using the DAVID bioinformatics database 55 and Ingenuity Pathways
Analysis software (Qiagen). The microarray dataset was deposited under the accession
code GSE110452.
Network Analysis
An interaction network was generated by using the GeneMANIA Cytoscape
plugin with default settings 56.
Chromatin Immunoprecipitation-Sequencing (ChIP-Seq)
FASTQ files corresponding to input (GEO Accession number: GSM1721243),
IRF8 ChIP (GEO Accession number: GSM1721244) 57 were downloaded from the

7

Table 2-1.

RT-PCR primer sequences

Gene
Naip1
Naip2
Naip5
Naip6
Nlrc4
Irf8
Nlrp3
Gapdh
Hprt

Strand
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

Sequence
މ-TGCCCAGTATATCCAAGGCTA-މ
މ-AGACGCTGTCGTTGCAGTAAG-މ
މ-TTTTGTGAATCCCTGGGTCA-މ
މ-TGTAGAAAAGGCCTGCTTTGA-މ
މ-AAGGAGATGACCCCTGGAAG-މ
މ-TGACCCAGGACTTCACAAAA-މ
މ-TTTTGTGAAGTCCTGGGTCAG-މ
މ-CAATGTCCTTTTTGCCAGTG-މ
މ-CAGGTGGTCTGATTGACAGC-މ
މ-CCCCAATGTCAGACAAATGA-މ
މ-GATCGAACAGATCGACAGCA-މ
މ-GCTGGTTCAGCTTTGTCTCC-މ
މ-TGCAGAAGACTGACGTCTCC-މ
މ-CGTACAGGCAGTAGAACAGTTC-މ
މ-CGTCCCGTAGACAAAATGGT-މ
މ-TTGATGGCAACAATCTCCAC-މ
މ-CTCATGGACTGATTATGGACAGGAC-މ
މ-GCAGGTCAGCAAAGAACTTATAGCC-މ
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Sequence Read Archive database by using SRA toolkit. FASTQ files were uploaded to
DNA Nexus (St. Jude Cloud), and sequence reads were mapped against the
GRCm38/mm10 genome build. Bedgraph files corresponding to IRF4 ChIP-seq
experiment were downloaded from GEO database (GEO Accession number:
GSE85172)58. BED files containing the enrichment scores for SPI1 binding were also
downloaded from GEO database (GEO Accession number: GSE77886) 36. The result was
visualized using Integrative Genomics Viewer (IGV) 59.
ChIP-PCR
WT BMDMs were cross-linked with 1% paraformaldehyde for 10 min followed
by glycin quenching. Samples were washed with ice cold PBS and scraped in PBS
supplemented with protease inhibitors. Cell pellets were incubated with SDS lysis buffer
for 10 min on ice followed by sonication using Covaris sonicator to obtain the desired
fragment length (300 bps to 700 bps). An equal amount of DNA was used for IgG
(control) (Cell Signaling Technology, 2729) and IRF8 (Cell Signaling Technology, 5628)
immunoprecipitation. Immunoprecipitated DNA was eluted in elution buffer and
amplified with primers for Naip2 and Naip5 (Table 2-2).
Luciferase Assay
The Naip2 and Naip5 promoter fragments nt -1kb to + 1kb, were amplified by
PCR using mouse genomic DNA as a template and inserted into the KpnI and XhoI sites
of the luciferase reporter plasmid pGL4.17 basic vector (Promega, E6721) yielding
reporter constructs pGL4.17 Naip2 and pGL4.17 Naip5 respectively. HEK293T cells
(ATCC, 3216) were co-transfected with the mixture of the indicated luciferase reporter
plasmid and pRL-TK-Renilla luciferase (Promega, E2241) plasmid using FuGENE
(Promega, E2311) according to manufacturer’s instructions. For inducing IRF8
expression, cells were transfected with pCMV6-mIRF8 vector (Origene, MR206748) and
luciferase activity was quantified 48 h after transfection with the Dual-Luciferase
Reporter Assay System (Promega, E1910) according to the manufacturer's instructions.
pcDNA3.1 (Invitrogen, V79020) was used as empty vector control.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extracts from BMDMs were prepared using NP-40 lysis buffer. EMSA
was performed using Light Shift Chemiluminescent EMSA kit (ThermoFisher Scientific,
20148). Analysis of IRF8 binding to predicted sites was performed using annealed biotin
labeled oligonucleotide probes in a 20 ȝOUHDFWLRQPL[WXUHIRUPLQDWURRPWHPSHUDWXUH
Samples were run on a non-denaturing 5% polyacrylamide gel and transferred to a nylon
membrane (ThermoFisher Scientific, 77016), cross-linked in UV.
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Table 2-2.
Gene
Naip2
Naip5

ChIP-PCR primer sequences
Strand
Forward
Reverse
Forward
Reverse

Sequence
މ-TTTCAACCTTACTACACTTTCAATCAAATAGAA-މ
މ-ATAGATAGATAGATATGGATATATAACC-މ
މ- AGTGCTGACACATTTGATGCCACCAATGCA-މ
މ- GCCCCCTTGCTGCTGATGCTCTGTGACCAG-މ

Complementation
Primary mouse BMDMs were transfected with the control pcDNA3.1 or pCMV6mIRF8 vector (Origene, MR206748) by nucleofection (ThermoFisher Scientific,
MPK10025) following the manufacturer’s instructions.
Animal Infection
Frozen stocks of S. Typhimurium or B. thailandensis were prepared from LBgrown S. Typhimurium or B. thailandensis, quantified prior to infection, and diluted in
PBS for infections. For S. Typhimurium infection, mice were injected intraperitoneally
with 103 CFU in 200 μL PBS. For B. thailandensis infection, mice were lightly
anesthetized with isoflurane and inoculated intranasally with 5 × 104 CFU in 50 μL PBS.
After 3 days of S. Typhimurium or 2 days of B. thailandensis infection, lungs, liver, and
spleen were collected and then homogenized for 2 min in PBS with metal beads by using
a TissueLyser II apparatus (Qiagen). CFU values were quantified by plating lysates onto
LB agar, followed by incubation overnight. No randomization or blinding was used.
Formalin preserved lungs were processed and embedded in paraffin according to standard
procedures. Sections (5 μm) were stained with H&E and examined.
Statistical Analysis
GraphPad Prism 6.0 software was used for data analysis. Data are shown as mean
± SEM. Statistical significance was determined by t tests (two-tailed) for two groups or
ANOVA (with Dunnett’s multiple comparisons test, Dunn’s multiple comparisons test, or
Tukey’s multiple comparisons test) for three or more groups. Survival curves were
compared with the log-rank test outcome. P values less than 0.05 were considered to be
statistically significant.
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CHAPTER 3.

RESULTS 2

IRF8 Is Dispensable for AIM2, NLRP3, and Pyrin Inflammasome Activation
Francisella tularensis, the agent responsible for causing tularemia in humans,
uses multiple strategies to evade immune surveillance 60. Importantly, AIM2 detects the
double-stranded DNA (dsDNA) of the bacterium following its exposure in cytosol 24,39. F.
tularensis subspecies novicida (F. novicida) triggered AIM2 inflammasome-dependent
cleavage of pro-caspase-1 (p45) into active caspase-1 (p20), subsequently producing
mature cytokines IL-1ȕ and IL-18, and inducing cell death in unprimed WT BMDMs.
Irf8–/– BMDMs were equally capable of cleaving caspase-1 as WT, producing IL-1ȕ and
IL-18, and pyroptosis following F. novicida infection, suggesting IRF8 had no role in
AIM2 inflammasome activation (Figure 3-1A, B, and C and Figure 3-2A). Because
IRF8 is involved in the development of immune cells 61, we examined the macrophage
markers F4/80 and CD11b. The enrichment of double-positive cell populations in Irf8–/–
BMDMs was comparable to that in WT BMDMs, indicative of normal in vitro
macrophage differentiation (Figure 3-3A).
Our group previously demonstrated that IRF1 is required to induce GBP2 and
GBP5, which mediate killing of F. novicida and liberation of bacterial DNA to induce
AIM2 inflammasome activation 26. In Irf8–/– BMDMs, the protein levels of GBP2 and
GBP5 were similar to those of control (Figure 3-3B). IRF1 is dispensable for cytosolic
poly(dA:dT)-mediated AIM2 inflammasome activation 26. To investigate the requirement
of IRF8 in response to poly(dA:dT), we transfected poly(dA:dT) into WT and Irf8–/–
BMDMs. Caspase-1 activation, IL-18 levels, and cell death in poly(dA:dT)-transfected
BMDMs from WT or Irf8–/– mice were comparable (Figure 3-1D, E, and F and Figure
3-2B).
Similarly, we did not observe a significant difference in canonical NLRP3
inflammasome (Figure 3-1G, H, and I and Figure 3-2C) or non-canonical NLRP3
inflammasome activation (Figure 3-1J, K, and L and Figure 3-2D). The levels of
inflammasome-independent cytokines (IL-6, TNF, and KC) were largely unaffected by
the absence of IRF8 (Figure 3-2).
Pyrin inflammasome activation is triggered by the inactivation of Rho GTPases,
which can be caused by bacterial cytotoxins 62. Toxin from C. difficile AB+ strain
induced Pyrin inflammasome activation that was not mediated by IRF8 (Figure 3-1M, N,
and O). These results excluded the requirement of IRF8 for AIM2, NLRP3, and Pyrin
inflammasome activation.

2

Modified from final submission with permission. Karki R*, Lee E*, Place D, Samir P, Mavuluri J,
Sharma BR, et al. IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. Cell. 2018
May 3;173(4):920-933.e13. (*Co-first author). https://doi.org/10.1016/j.cell.2018.02.055 [76].
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Figure 3-1. IRF8 does not affect the activation of AIM2, NLRP3, or Pyrin
inflammasomes
(A) Immunoblot analysis of pro-caspase-1 (p45) and the cleaved caspase-1 (p20) in WT
or mutant BMDMs left untreated/uninfected (Media) or infected with F. novicida
(multiplicity of infection [MOI], 100) and collected after 20 h.
(B) Assessment of IL-18 release by enzyme-linked immunosorbent assay (ELISA)
following F. novicida infection.
(C) Images of BMDMs under light microscopy after F. novicida infection. The arrows
indicate pyroptotic cells.
(D–F) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs after
transfection with poly(dA:dT).
(G–I) Immunoblot analysis of caspase-1, IL-18 release, and cell images of LPS-primed
BMDMs stimulated with ATP.
(J–L) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs
primed with LPS and followed by LPS transfection.
(M–O) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs
following treatment of toxin from C. difficle AB+ strain.
6FDOHEDUVȝP &),/DQG2 16QRWVLJQLILFDQW 3
3DQG
****P < 0.0001 (One-way ANOVA with Dunnett’s multiple comparisons test). Data are
representative of 3 (A, C, D, F, G, I, J, L, M, and O) or from 3 (B, E, H, K, and N)
independent experiments (mean ± SEM).
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Figure 3-2. Inflammasome-independent cytokine secretion and cell death in
response to various stimuli are not altered by IRF8
(A) Release of cytokines IL-1ȕ, IL-6, TNF and lactate dehydrogenase (LDH) in BMDMs
after infection with F. novicida (MOI, 100).
(B) Release of IL-6, TNF, KC and LDH in BMDMs transfected with poly(dA:dT).
(C) Release of IL-1ȕ, IL-6, TNF and LDH in BMDMs primed with LPS and stimulated
with ATP.
(D) Release of IL-6, TNF, KC and LDH in BMDMs primed with LPS and transfected
with LPS.
NS, not significant; **P < 0.01 and ***P < 0.001 (One-way ANOVA with Dunnett’s
multiple comparisons test). Data are from 3 independent experiments (mean ± SEM).
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Figure 3-3. IRF8 is necessary for NLRC4 inflammasome activation in various
doses of bacterial infection
(A) Flow cytometric analysis of side-scattered light (SSC), forward-scattered light (FSC);
and expression of F4/80 and CD11b of BMDMs generated from WT and Irf8–/– mice.
(B) Immunoblot analysis of IRF8, GBP2, GBP5, and ȕ-actin (loading control) in
BMDMs at various times after infection with F. novicida.
(C–E) Immunoblot analysis of caspase-1 in BMDMs that were infected with multiple
MOIs of S. Typhimurium, P. aeruginosa, or B. thailandensis.
(F) Immunoblot analysis of IRF8 in BMDMs stimulated with LPS or infected with S.
Typhimurium or B. thailandensis.
Data are representative of 2 independent experiments.
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IRF8 Is Required for Optimal NLRC4 Inflammasome Activation
Salmonella Typhimurium-Dependent NLRC4 Inflammasome Activation
The NLRC4 inflammasome is critical for determining the response to bacterial
pathogens that have gained access to the cytosol. Salmonella, a Gram-negative bacteria
whose primary route of infection in mice and humans is through the gastrointestinal tract,
was one of the first microbes identified to activate the NLRC4 inflammasome 8. Other
bacterial species characterized to engage NLRC4 inflammasome are Pseudomonas
aeruginosa, Burkholderia thailandensis, and Legionella pneumophila 12,15,63,64. We
infected WT BMDMs with Salmonella enterica subspecies enterica serovar
Typhimurium (S. Typhimurium), which resulted in robust caspase-1 activation (Figure
3-4A). Surprisingly, reduced caspase-1 activation was observed in infected Irf8–/–
BMDMs (Figure 3-4A and Figure 3-3C). IL-18 and IL-1ȕ production was dampened,
with fewer pyroptotic cells (Figure 3-4B, C and Figure 3-5A). Collectively, all features
of caspase-1 activation were attenuated in the absence of IRF8 in response to S.
Typhimurium infection.
Many pathogenic bacteria including Salmonella species harbor flagella and the
evolutionarily related T3SS as important virulence mechanisms, which activate the
NLRC4 inflammasome. Flagellin monomers form the filamentous flagellum that confers
motility. The T3SS is composed of a basal body, connecting rod, and needle that
altogether serves as a molecular syringe to inject various effector proteins into the host
cytosol, inflicting intracellular perturbations beneficial to the invasion of the
bacterium 65–67. Previous studies have utilized flagellin-mutant S. Typhimurium to
delineate the specific role of flagellin in activating the NLRC4 inflammasome 6,7. S.
7\SKLPXULXPODFNLQJIODJHOOLQSURWHLQV)OL&DQG)OM% ǻfliCǻfljB) was still able to elicit
caspase-1 activation and cell death in WT BMDMs that was largely dependent on
NLRC4 (Figure 3-4D and Figure 3-5B, C ǻfliCǻfljB can activate the NLRC4
inflammasome alternatively by T3SS 15. Infection with ǻfliCǻfljB in Irf8–/– BMDMs
revealed reduced caspase-1 activation, IL-18 release, and cell death, suggesting that IRF8
is necessary for T3SS-dependent NLRC4 inflammasome activation (Figure 3-4D, F and
Figure 3-5B, C). The residual caspase-1 cleavage observed in cells lacking NLRC4
might be due to NLRP3 inflammasome activation 9,68. To address this question, we
infected Nlrp3–/–Nlrc4–/– BMDMs with ǻfliCǻfljB, which exhibited defective caspase-1
activation, IL-18 production, and cell death (Figure 3-4E, F and Figure 3-5B, C).
There are two versions of Salmonella T3SS that are encoded separately by
Salmonella pathogenicity island-1 (SPI-1) and SPI-2. SPI-1 T3SS is expressed to
promote cell invasion in early stages of infection until Salmonella establishes its
replicative niche in the phagocytic compartment Salmonella-containing vesicle (SCV),
where it downregulates flagellin and SPI-1 T3SS expression and switches to SP1-2
T3SS65. SPI-1 was critical for inflammasome activation in response to S. Typhimurium
EHFDXVHWKHǻSPI-1 strain was unable to activate caspase-1 (Figure 3-4G). In contrast,
ǻSPI-2 infection was able to induce NLRC4 inflammasome–mediated caspase-1
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Figure 3-4. IRF8 is necessary for NLRC4 inflammasome activation induced by
bacterial infection
(A–C) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs that
were infected with S. Typhimurium (MOI, 0.1) and collected after 4 h.
(D and E) Immunoblot analysis of caspase-1 in BMDMs that were infected with
ǻfliCǻfljB S7\SKLPXULXP ǻfliCǻfljB) (MOI, 1) and collected after 4 h.
(F) Assessment of IL-18 levels in cell supernatants folORZLQJǻfliCǻfljB infection.
(G) Immunoblot analysis of caspase-LQ%0'0VWKDWZHUHLQIHFWHGZLWKǻSPI-1 S.
7\SKLPXULXP ǻSPI-1) (MOI, 1) and collected after 4 h.
(H) Immunoblot analysis of caspase-LQ%0'0VWKDWZHUHLQIHFWHGZLWKǻSPI-2 S.
TyphimuriuP ǻSPI-2) (MOI, 1) and collected after 4 h.
(I) Assessment of IL-OHYHOVLQFHOOVXSHUQDWDQWVIROORZLQJǻSPI-2 infection.
(J–L) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs after
P. aeruginosa (MOI, 1) infection for 4 h.
(M–O) Immunoblot analysis of caspase-1, IL-18 release, and cell images of BMDMs
after B. thailandensis (MOI, 1) infection for 4 h.
6FDOHEDUVȝP &/DQG2 16QRWVLJQLILFDQW 3 3
3
0.001 and ****P < 0.0001 (One-way ANOVA with Dunnett’s multiple comparisons test).
Data are representative of 3 (A, C, D, E, G, H, J, L, M, and O) or from 3 (B, F, I, K, and
N) independent experiments (mean ± SEM).
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Figure 3-5. IRF8 is required for NLRC4 inflammasome activity but not for
inflammasome-independent cytokine release after various bacterial infections
(A) Release of IL-1ȕ, TNF, IL-6 and LDH in BMDMs after infection with S.
Typhimurium (MOI, 0.1).
(B and C) Microscopic images and cell death analysis of BMDMs infected with
ǻfliCǻfljB 02, RUǻSPI-2 (MOI, 1).
(D) Release of IL-1ȕ, TNF, IL-6 and LDH in BMDMs after infection with P. aeruginosa
(MOI, 1).
(E) Release of IL-1ȕ, TNF, IL-6 and LDH in BMDMs after infection with B.
thailandensis (MOI, 1).
6FDOHEDUVȝP % 16QRWVLJQLILFDQW 3 3
3DQG
****P < 0.0001 (One-way ANOVA with Dunnett’s multiple comparisons test). Data are
representative of 3 (B) or from 3 (A and C–E) independent experiments (mean ± SEM).
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activation, IL-18 secretion, and pyroptosis in WT BMDMs, and to a lesser degree, in
Irf8–/– BMDMs (Figure 3-4H, I and Figure 3-5B, C). These results suggest that IRF8
plays a role in NLRC4 inflammasome activation that is dependent on functional SPI-1
T3SS of Salmonella.
P. aeruginosa and B. thailandensis-Dependent NLRC4 Inflammasome Activation
We further investigated the contribution of IRF8 to NLRC4 inflammasome
activation by infecting BMDMs with other bacteria that engage the NLRC4
inflammasome. P. aeruginosa activated caspase-1 in WT BMDMs, leading to IL-18 and
IL-1ȕ secretion and pyroptotic cell death. Indeed, Irf8–/– BMDMs had less caspase-1
activation, IL-18 and IL-1ȕ, and cell death than WT (Figure 3-4J, K, and L, Figure
3-3D, and Figure 3-5D). Consistently, the extent of NLRC4 inflammasome activity was
reduced in Irf8–/– BMDMs after infection with B. thailandensis (Figure 3-4M, N, and O,
Figure 3-3E, and Figure 3-5E). However, there was no defect in inflammasomeindependent cytokine production upon these bacterial infections (Figure 3-5A, D, and E).
IRF8 was constitutively expressed and its expression did not change significantly under
our experimental conditions that promoted a variety of pro-inflammatory cytokines
(Figure 3-3F). Further supporting our observations, silencing Irf8 in BMDMs resulted in
decreased caspase-1 cleavage compared to that of control siRNA-treated BMDMs
infected with S. Typhimurium, but not in those infected with F. novicida (Figure 3-6A,
B). In addition, caspase-1 activation and cell death in Irf8–/– BMDMs infected with S.
Typhimurium was less than that of Irf8+/– BMDMs (Figure 3-6C, D). Altogether, our
findings highlight the importance of IRF8 to enable recognition of bacterial components
during infection for NLRC4 inflammasome activation.
IRF8 Is Required for Expression of Murine Naips
Differential Expression of NLRC4 Inflammasome Components
NAIPs belong to the NLR family of pattern recognition receptors (PRRs) and
contain repeats of the inhibitor of apoptosis (IAP) domain also known as the Baculovirus
inhibitor of apoptosis protein repeat (BIR) domain 69. Association of each NAIP with its
specific bacterial protein drives assembly and activation of the NLRC4 inflammasome. In
mice, the corresponding NAIPs and ligands are NAIP1 for the T3SS needle, NAIP2 for
the T3SS inner rod, and NAIP5 and NAIP6 for flagellin 13. Humans encode a single
NAIP that has the highest sequence homology with murine NAIP1 and appears to
recognize needle, rod, and flagellin 18–20. In our experiments with bacterial infection, we
identified the requirement of IRF8 for optimal NLRC4 inflammasome activation (Figure
3-4). Following these observations, we performed microarray to examine possible
differential regulation of innate immune sensors in WT and Irf8–/– BMDMs upon
infection with S. Typhimurium. We found reduced expression of genes encoding for
NAIP6, NAIP5, NAIP2, and NLRC4; all critical components of the NLRC4
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Figure 3-6. Absence of IRF8 attenuates NLRC4 activation
(A) Immunoblot analysis of caspase-1 in WT BMDMs transfected with a control siRNA
or Irf8 siRNA and then infected with S. Typhimurium (MOI, 0.1) for 4 h or F. novicida
(MOI, 100) for 20 h. Nlrc4–/– (left) or Aim2–/– (right) BMDMs were used as controls.
(B) Relative expression of the gene encoding IRF8 in WT BMDMs transfected with a
control siRNA or Irf8 siRNA.
(C) Immunoblot analysis of caspase-1 in BMDMs that were infected with S.
Typhimurium (MOI, 0.1) and collected after 4 h.
(D) Microscopic images of BMDMs that were infected with S. Typhimurium (MOI, 0.1).
(E) Immunoblot analysis of caspase-1 in BMDMs that were transfected with different
doses of flagellin.
(F and G) Release of IL-1ȕ and KC in BMDMs treated with DOTAP, transfected with
flagellin (DOTAP + Flgn), or treated with flagellin (Flgn).
(H and I) Immunoblot analysis of caspase-1 and assessment of IL-18 levels in BMDMs
untreated or transfected with flagellin.
(J) Microscopic images of BMDMs transfected with PrgI (DOTAP + PrgI) or PrgJ
(DOTAP + PrgJ).
6FDOHEDUVȝP 'DQG- 16QRWVLJQLILFDQW 3 3
3
and ****P < 0.0001 (One-way ANOVA with Dunnett’s multiple comparisons test). Data
are from 3 (F and G) or 2 (I) or representative of 2 (A–E, H, and J) independent
experiments (mean ± SEM).
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inflammasome complex (Figure 3-7A).
To find the regulatory interactions involving the NLRC4 inflammasome, we first
generated a network of interactions between IRF8 and NAIPs (not shown) where IRF8
physically interacted with IRF4. Interestingly, IRF4 has the greatest sequence homology
with IRF8 and requires SPI1 (also known as PU.1) as a binding partner to govern
transcriptional programs in the B-cell lineage 70. Our subsequent generation of an
interaction network involving IRF4 and NAIPs revealed the co-expression between Irf8
and Spi1. Moreover, Irf8 was co-expressed with Naip2, Naip5, Naip6, and Nlrc4 but not
with Naip1. The selected group of proteins exhibited clique-like properties, with each
node being connected to most of the other nodes, suggesting a potential functional
interaction (Figure 3-7B).
Transcriptional Regulation of NLRC4 Inflammasome
To address how NAIPs are being regulated by IRF8, we reanalyzed a published
Chromatin immunoprecipitation-sequencing (ChIP-seq) dataset 57. Sequences mapping to
the promoter regions of Naip2, Naip5 and Naip6 were enriched, suggesting that their
expression can be regulated by IRF8. We found no enrichment of sequences mapping to
the Naip1 promoter. Although we did not find enrichment in the promoter region of
Nlrc4, we identified an IRF8 binding site in the intronic region. Transcription factor
binding in the introns have previously been reported to regulate transcription of target
genes 71,72. IRF8 binding in the intron might be regulating Nlrc4 expression by increasing
chromatin accessibility for other transcription factors (Figure 3-7C). Real-time PCR
(RT-PCR) analysis confirmed that Naip1, Naip2, Naip5, and Naip6 had reduced gene
expression in response to S. Typhimurium in Irf8–/– BMDMs relative to WT BMDMs
(Figure 3-7D). We also observed similar results when cells were transfected with
flagellin (Figure 3-7E). Importantly, there was a basal defect in the transcription of all
the Naips and Nlrc4, but not for the control gene Nlrp3 (Figure 3-7D, E, and F).
Collectively, we show that IRF8 likely has binding sites in Naip promoters, contributing
to the steady-state expression of Naips.
IFN signaling is important for the regulation of IRF8 29. Therefore, it might be
possible that the molecules related to IFN production and signaling involve in the
regulation of NAIPs. However we found similar gene expression of Naips and Nlrc4 in
the BMDMs lacking IRF1, IRF3, IRF7, IRF3 and IRF7, IRF5, IRF9, IFNAR1, IFNAR2,
STAT1, TRIF, MAVS, MDA5, cGAS, and STING, suggesting IRF8 specifically
regulates Naips independent of IFN signaling (Figure 3-8). Our interaction map reveals a
close network between IRF8, IRF4, and Ets family member SPI1 (Figure 3-7B). When
we analyzed another published ChIP-seq dataset 58, there was no enrichment of IRF4
binding to Naip2 or Naip5 promoters. (Figure 3-7G). In addition we checked for SPI1
binding sites 36, where we found enrichment of SPI1 binding to Naip1, Naip2, Naip5, and
Naip6 loci. This data suggests that SPI1 might work in conjunction with IRF8 for the
transcriptional regulation of Naips (Figure 3-7H).
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Figure 3-7. IRF8 is a key factor in transcriptional regulation of Naips
(A) Microarray analysis of the expression of PRR-encoding genes 4 h after infection with
S. Typhimurium (MOI, 0.1) in Irf8–/– BMDMs relative to that of WT.
(B) Interaction network visualizing the associations between IRF8, IRF4, SPI1, NLRC4,
and NAIPs.
(C) Chromatin immunoprecipitation-sequencing (ChIP-seq) for IRF8 binding in Naip1,
Naip2, Naip5, Naip6, and Nlrc4. Peaks indicate regions of DNA bound by IRF8.
(D) Real-time PCR (RT-PCR) analysis of genes encoding NAIPs in BMDMs before (0 h)
and after (1 h or 3 h) infection with S. Typhimurium, normalized with the gene encoding
HPRT.
(E) RT-PCR analysis of genes encoding NAIP5 and NAIP6 in BMDMs before (0 h) and
after (1 h or 3 h) transfection with 0.5 μg flagellin, normalized with the gene encoding
HPRT.
(F) RT-PCR analysis of genes encoding NLRP3 and NLRC4 in untreated BMDMs,
normalized with the gene encoding HPRT.
(G) ChIP-seq for IRF4 binding in Naip2 and Naip5.
(H) ChIP-seq for SPI1 binding in Naip1, Naip2, Naip5, and Naip6, shown as MACS2
called peaks.
NS, not significant; and **P < 0.01 (two-tailed t test). Data (D–F) are from 3 independent
experiments (mean ± SEM).
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Figure 3-8. Gene expression of Naips is unaltered in BMDMs deficient in IFN
pathway molecules
RT-PCR analysis of genes encoding NAIPs and NLRC4 in BMDMs, normalized with the
gene encoding HPRT. Data are from 2 independent experiments (mean ± SEM).
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To validate IRF8 binding to Naip promoters found in the public ChIP analysis, we
designed primer sets specific to the IRF8 consensus sequence at -590 and -390 on the
promoter regions of Naip2 and Naip5, respectively, to perform targeted ChIP-PCR. The
samples immunoprecipitated with IRF8 antibody but not the control IgG antibody yielded
amplified PCR products, suggesting the recruitment of IRF8 onto the Naip2 and Naip5
promoters (Figure 3-9A). Next, to gain further insight into the molecular mechanism of
IRF8-mediated transcription of Naips, we cloned the promoters of Naip2 or Naip5 into a
luciferase reporter vector. Luciferase expression was significantly upregulated in cells
that were co-transfected with Irf8 compared to those transfected with empty vectors,
which suggested that IRF8 regulates mRNA abundance of Naip2 and Naip5 at the level
of transcription (Figure 3-9B). Furthermore we sought to confirm the direct recruitment
of IRF8 to Naip promoters. To this end, we performed electrophoretic mobility shift
assay (EMSA) where we observed IRF8 binding to Naip2 and Naip5 promoters in
nuclear extracts from WT BMDMs (Figure 3-9C). To determine whether the binding
was specific to IRF8, we utilized competitive EMSA and antibody-mediated super shift
assays. Non-labeled Naip2 or Naip5 oligonucleotides successfully competed with the
labeled probes and addition of IRF8 antibody abolished the migration of the IRF8-Naip
promoter complex into the membrane (Figure 3-9C). Together, these results establish
that IRF8 directly binds to the promoters of Naip2 and Naip5 to regulate their expression.
To further corroborate these findings, we reconstituted IRF8 in Irf8–/– BMDMs.
Compared to untreated or control-transfected cells, reconstitution of IRF8 increased the
expression of Naip1, Naip2, Naip5, and Naip6. (Figure 3-9D). All these findings
mechanistically prove that IRF8 regulates Naips at the transcriptional level.
Functional Regulation of Individual NAIPs
Furthermore, we examined the role of IRF8 in NLRC4 inflammasome activation
in response to bacterial flagellin and components of the T3SS apparatus. Flagellin
treatment alone without the transfection agent DOTAP failed to induce processing of
caspase-1. Intracellular delivery of flagellin led to caspase-1 activation in WT BMDMs
but activation was greatly impaired in Irf8–/– BMDMs (Figure 3-10A and Figure 3-6E).
In line with these observations, inflammasome-dependent cytokines IL-18 and IL-1ȕ
were reduced whereas KC was unaffected by the absence of IRF8 (Figure 3-10B and
Figure 3-6F, G). Correspondingly, BMDMs lacking IRF8 were compromised in their
ability to undergo pyroptosis after flagellin transfection (Figure 3-10C, D). Because
NAIP5 is the receptor for cytosolic flagellin recognition, we checked for inflammasome
activation in Naip5–/– BMDMs transfected with flagellin. As expected, caspase-1
maturation and IL-18 production were diminished in cells lacking NAIP5 to a similar
extent as seen in cells lacking NLRC4 (Figure 3-6H, I). Irf8–/– BMDMs also had
decreased inflammasome activity in response to bacterial T3SS. Transfection of the
needle protein PrgI or the rod protein PrgJ into Irf8–/– BMDMs resulted in reduced
caspase-1 activation, IL-18 release, and cell death compared to that of WT (Figure 3-10E
through J and Figure 3-6J). These results demonstrate the significance of IRF8 for sterile
NLRC4 inflammasome activation triggered by pure ligands of NAIPs.

29

Figure 3-9. Transcriptional activity of IRF8 for Naips
(A) ChIP for IRF8 followed by semi-quantitative PCR for Naip2 or Naip5 promoters
were performed in BMDMs.
(B) Relative reporter luciferase activity for Naip2 or Naip5 promoters in IRF8
overexpressing cells, presented as fold change with respect to empty vector (EV)
transfected cells. Data was normalized for transfection efficiency by normalizing firefly
luciferase activity with renilla luciferase activity.
(C) Electrophoretic mobility shift assay (EMSA) was performed with Naip2 or Naip5
oligonucleotide probes incubated with nuclear protein extracts (NPE) from BMDMs.
(D) RT-PCR analysis of Naip1, Naip2, Naip5, Naip6, and Irf8 in Irf8–/– BMDMs
transfected with control or Irf8 vectors, normalized to levels of Gapdh.
NS, not significant; *P < 0.05, **P < 0.01, and ****P < 0.0001 (two-tailed t test). Data
are representative of 2 (A and C) or from 2 (B and D) independent experiments (mean ±
SEM).
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Figure 3-10. NLRC4 inflammasome activation in response to isolated bacterial
proteins is impaired in the absence of IRF8
(A–D) BMDMs were treated with the liposomal agent DOTAP alone, transfected with
0.5 ȝJIODJHOOLQ '27$3)OJQ RUWUHDWHGZLWK ȝJIODJHOOLQ )OJQ DORQH
(A) Immunoblot analysis of caspase-1.
(B) Assessment of IL-18 levels in cell supernatants.
(C) Microscopic analysis of cell death.
(D) Cell death was assessed by evaluating the release of LDH.
(E–G) Immunoblot analysis of caspase-1, IL-18 release, and cell death in BMDMs
transfected with PrgI (DOTAP + PrgI) or treated with PrgI alone.
(H–J) Immunoblot analysis of caspase-1, IL-18 release, and cell death in BMDMs
transfected with PrgJ (DOTAP + PrgJ) or treated with PrgJ alone.
6FDOHEDUVȝP & 16QRWVLJQLILFDQW 3 3DQG
3
(One-way ANOVA with Dunnett’s multiple comparisons test). Data are representative of
3 (A and C) or 2 (E and H) or from 3 (B and D) or 2 (F, G, I, and J) independent
experiments (mean ± SEM).
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IRF8 Protects Against S. Typhimurium and B. thailandensis Infection In Vivo
Susceptibility to In Vivo Infection
NLRC4 inflammasome activation is required for bacterial clearance in S.
Typhimurium infected mice 73. To examine the in vivo relevance of IRF8 we infected
mice intraperitoneally with S. Typhimurium and monitored body weight change and
mortality during the course of infection. Compared to WT mice, Irf8–/– mice exhibited
rapid weight loss between day 1 and day 2 which was similar to the degree of wasting in
Nlrc4–/– mice. On the other hand Irf8+/– mice followed the trend of WT mice, showing a
gradual decrease in body weight and successive recovery (Figure 3-11A). All Irf8–/– mice
succumbed to infection within 4 days, while during the same time 100% of the Irf8+/– and
WT mice were still alive. We continued monitoring until day 12 in which the
accumulated mortality of Irf8+/– and WT mice was about 50%. The high susceptibility of
Nlrc4–/– mice, as reported 73, was comparable to that of Irf8–/– mice (Figure 3-11B). The
accelerated mortality of mice lacking IRF8 or NLRC4 highlights the importance of early
innate immune responses to contain the pathogen which in turn greatly affects the
outcome of the infection. Moreover, Irf8–/– mice were more susceptible to B.
thailandensis infection. Within 4 days all Irf8–/– mice died, but more than 50% of WT
mice survived (Figure 3-12A). Interestingly, Naip5–/– mice were more susceptible to S.
Typhimurium infection than WT mice but still more resistant than Irf8–/– or Nlrc4–/– mice
(Figure 3-11B). This intermediate phenotype suggests that other NAIPs also contribute
to mount NLRC4 inflammasome activation in response to S. Typhimurium infection in
vivo.
The bacterial burden in the spleen and liver of Irf8–/– or Nlrc4–/– mice was greater
than that of WT mice upon S. Typhimurium infection (Figure 3-11C, D). Similarly, Irf8–
/–
mice had increased bacterial burden in the lung, liver, and spleen after B. thailandensis
infection compared to WT mice (Figure 3-12B). IL-18 levels in the spleen, liver, and
serum of these mice were also assessed 3 days after S. Typhimurium infection, or 2 days
after B. thailandensis infection. Less IL-18 was detected in the tissues and serum of Irf8–
/–
mice than in those of WT, reflecting defective inflammasome activation in response to
infection in Irf8–/– mice (Figure 3-11E, F and Figure 3-12C). Furthermore, we
investigated the numbers of circulating blood cells from the peripheral blood of infected
WT and Irf8–/– mice using an automated hematology analyzer. Relative to WT mice, Irf8–
/–
mice exhibited higher numbers of total white blood cells (WBCs), neutrophils, and
lymphocytes 3 days after S. Typhimurium infection, whereas no significant differences
were noted in the numbers of other cell types (Figure 3-13A). Similarly, we found more
circulating WBCs and neutrophils in Irf8–/– mice 2 days after B. thailandensis infection,
suggesting that the susceptibility of IRF8-deficient mice to infection was not due to
impaired immune cell production and circulation (Figure 3-13B). However, we observed
more prominent recruitment of immune cells, which were largely composed of
neutrophils, in the lungs of B. thailandensis-infected WT mice than in the lungs of Irf8–/–
mice (Figure 3-12D). This may be due to the decreased production of inflammasomedependent cytokines in IRF8-deficient mice.
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Figure 3-11. IRF8 confers protection against S. Typhimurium in vivo
(A) Body weight of 8-week-old WT (n=13), Irf8–/– (n=7), Irf8+/– (n=6) and Nlrc4–/– (n=9)
mice infected intraperitoneally with 103 colony forming units (CFU) of S. Typhimurium.
(B) Survival of WT (n=13), Irf8–/– (n=7), Irf8+/– (n=6), Naip5–/–(n=9), and Nlrc4–/– (n=9)
mice infected as (A).
(C and D) Bacterial burden in the spleen and liver of WT (n=20), Irf8–/– (n=15), Nlrc4–/–
(n=15) and Naip5–/–(n=9) mice on day 3 after infection as (A).
(E and F) Analysis of IL-18 in the spleen and liver collected from WT (n=10), Irf8–/–
(n=6), Nlrc4–/– (n=10) and Naip5–/– (n=6) mice on day 3 after infection as (A).
(G–L) RT-PCR analysis of genes encoding NAIPs, NLRC4, and IRF8 in the spleen
collected from WT and Irf8–/– mice before infection (day 0) and after infection (day 3) as
(A), normalized with the gene encoding HPRT.
NS, not significant; *P < 0.05, ***P < 0.0001 and ****P < 0.0001 (log-rank test [B],
ANOVA with Dunn’s multiple comparisons test [C–F], or Two-way ANOVA with
Tukey’s multiple comparisons test [G–L]). Data are from 2 experiments.
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Figure 3-12. IRF8 confers protection against B. thailandensis in vivo
(A) Survival of 8-week-old WT (n=11) and Irf8–/– (n=7) mice infected intranasally with 5
× 104 CFU of B. thailandensis.
(B) Bacterial burden in the lungs, liver and spleen of WT (n=10) and Irf8–/– (n=9) mice
on day 2 after infection as (A).
(C) Analysis of IL-18 in the lungs, liver, spleen, and serum collected from WT (n=10)
and Irf8–/– (n=9) mice on day 2 after infection as (A).
(D) H&E staining of lungs collected from WT and Irf8–/– mice on day 2 after infection as
(A).
(E–H) RT-PCR analysis of genes encoding NAIPs and NLRC4 in spleen and lungs
collected from WT (n=10) and Irf8–/– (n=9) mice before (day 0) and after infection (day 2)
as (A), normalized with the gene encoding HPRT.
Scale bars, 250 ȝP ' 16QRWVLJQLILFDQW 3 3
3DQG
****P < 0.0001 (log-rank test [A] or two-tailed t test [B and C] or Two-way ANOVA
with Tukey’s multiple comparisons test [E–H]). Data are representative of 2 (D) or from
2 (A–C and E–H) independent experiments.
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Figure 3-13. IRF8-deficient mice have sufficient numbers of circulatory immune
cells following infection
(A) Blood cell counts from peripheral blood of WT (n=10), Irf8–/– (n=6), and Nlrc4–/–
(n=10) mice on day 3 after intraperitoneal infection with 103 CFU of S. Typhimurium.
(B) Blood cell counts from peripheral blood of WT (n=10) and Irf8–/– (n=9) mice on day
2 after intranasal infection with 5 × 104 CFU of B. thailandensis.
NS, not significant; *P < 0.05, **P < 0.01 and ***P < 0.001 (One-way ANOVA with
Dunnett’s multiple comparisons test [A] or two-tailed t test [B]). Data are from 1
independent experiment.
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The main effectors of inflammasome activation are the cytokines IL-1ȕ and IL-18,
and the recently identified pore-forming molecule gasdermin D 2–4. We used the above S.
Typhimurium infection model to further access the relative contribution of cytokine
production and pyroptosis in host defense. The body weight of Il18–/–Il1r–/–, Gsdmd–/–,
and Casp1–/– mice dropped significantly during the first few days of infection compared
to WT mice (Figure 3-14A). In 4 days, all mice from the three knock-out genotypes
succumbed to infection, without showing any significant difference between the groups
(Figure 3-14B). In comparison to WT mice, the bacterial loads of Gsdmd–/– mice and
Il18–/–Il1r–/– mice were greater, supporting the idea that inflammasome-dependent
cytokines and cell death were both critical in mediating host defense against S.
Typhimurium infection (Figure 3-14C).
Tissue Expression of Naips
Finally, we examined Naip gene expression patterns in the spleen of WT and Irf8–
mice before and after infection with S. Typhimurium. Irf8–/– mice had basally lower
expression of Naip1, Naip5, Naip6, Nlrc4, but not Naip2 than WT mice (Figure 3-11G
through K). After infection, Naip1 and Naip6 gene expression remained lower in Irf8–/–
mice compared to that of WT mice (Figure 3-11G, J). In WT mice we observed
significant reduction in the gene expression of Naip1 and Naip5 after infection, which
might be due to reduction in the levels of Irf8 (Figure 3-11G, I, and L). Similarly, we
observed lower gene expression of Naip1, Naip5, and Naip6 in the spleen of Irf8–/– mice
compared to those of WT mice after B. thailandensis infection (Figure 3-12E, G).
However, in the lungs we observed decreased expression of Naip2 along with other Naips
and Nlrc4 before and after B. thailandensis infection (Figure 3-12F, H). Thus, in the
absence of IRF8, infected mice were not able to promote sufficient inflammasome
activation due to the lack of Naips expression. These data display an important role for
IRF8 in regulating the NLRC4-dependent clearance of S. Typhimurium and B.
thailandensis.

/–
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Figure 3-14. Inflammasome-dependent cytokines and pyroptosis both contribute to
protection against S. Typhimurium infection in vivo
(A) Body weight of 8-week-old WT (n=13), Il18–/–Il1r–/– (n=4), Gsdmd–/– (n=9), Casp1–/–
(n=7), and Irf8–/– (n=8) mice infected intraperitoneally with 103 CFU of S. Typhimurium.
(B) Survival of WT (n=13), Il18–/–Il1r–/– (n=4), Gsdmd–/– (n=9), Casp1–/– (n=7), and Irf8–
/–
mice infected as (A).
(C) Bacterial burden in tissues. For spleen, WT (n=10), Il18–/–Il1r–/– (n=11), Gsdmd–/–
(n=11), Casp1–/– (n=8), and Irf8–/– (n=7) mice; for liver, WT (n=10), Il18–/–Il1r–/– (n=12),
Gsdmd–/– (n=11), Casp1–/– (n=7), and Irf8–/– (n=7) mice on day 3 after infection as (A).
NS, not significant; **P < 0.001 and ***P < 0.0001 (log-rank test [B] or ANOVA with
Dunn’s multiple comparisons test [C]). Data are from 1 experiment.
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CHAPTER 4.

DISCUSSION 3,4

IRF8 and the Inflammasome
In comparison to the well-studied NLRP3 inflammasome, how NLRC4
inflammasome activity is controlled has been unknown. Activation of the NLRC4
inflammasome is crucial for defense against pathogenic bacteria that harbor flagellin or
the T3SS. Mice lacking NLRC4 or NAIPs have increased bacterial loads. The NLRC4
inflammasome promotes bacterial clearance by the expulsion of bacteria-containing
intestinal epithelial cells from S. Typhimurium-challenged mice 74,75. We discovered that
IRF8 mediates NLRC4 inflammasome activation by transcriptionally regulating NAIPs,
thereby enabling cellular detection of flagellin or T3SS proteins. In vivo, we found IRF8
is important for NLRC4 inflammasome-dependent cytokine production, bacterial
clearance, and ultimately, host survival 76,77. Previous studies have demonstrated that type
IFNs and IRF1 contribute to bacteria-induced AIM2 and non-canonical NLRP3
inflammasome activation 21–24,26. By introducing IRF8 as a novel player in inflammasome
regulation, our findings also suggest a common cellular function for IRFs in promoting
inflammasome activation during bacterial infection.
Although our study has convincingly demonstrated the role of IRF8 in
transcriptional regulation of NAIPs, there are also other mechanisms by which IRF8
could modulate NLRC4 inflammasome activation. One study found that IRF8-dependent
autophagy is important for the clearance of Listeria monocytogenes in macrophages 78.
As the relation between inflammasomes and autophagy is being increasingly explored, it
would be interesting to know how NLRC4 inflammasome activation is affected by this
fundamental cellular process. Also, phosphorylation of NLRC4 is required for
LQIODPPDVRPHDFWLYDWLRQDQG3.&įLVLQYROYHGLQWKLVHYHQt 79. Prkcd, the gene
HQFRGLQJ3.&įZDVXSUHJXODWHGDIWHULQGXFHGH[SUHVVLRQRI,5)LQDP\HORLG
progenitor cell line 80. This raises the question as to whether IRF8 could have additional
roles upstream of NLRC4 inflammasome activation. In addition, apart from controlling
inflammasome activation, IRF8 is known for promoting development of cDC1s and
pDCs 81, which might also have contributed to the increased susceptibility of Irf8–/– mice
to Salmonella and Burkholderia infections.

3

Portions of chapter from previously published article; modified from final submission with permission.
Karki R*, Lee E*, Place D, Samir P, Mavuluri J, Sharma BR, et al. IRF8 Regulates Transcription of Naips
for NLRC4 Inflammasome Activation. Cell. 2018 May 3;173(4):920-933.e13. (*Co-first author).
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4
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permission. Lee E, Karki R, Kanneganti T-D. The NLRC4 inflammasome requires IRF8-dependent
production of NAIPs. Cell Stress. 2018 May 22;2(6):144–6. https://doi.org/10.15698/cst2018.06.141 [77].
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Additional Factors That May Regulate NLRC4 Inflammasome
The residual expression of Naips and NLRC4 inflammasome activity in the
absence of IRF8 imply that other factors may also contribute to the transcription of
NAIPs. IRF8 is known to be recruited with other transcription factors owing to its weak
DNA-binding activity. IRF, AP-1, and Ets family transcription factors interact with IRF8
to bind to specific composite elements allowing combinatorial control over numerous
genes 27,82,83. In our network analysis, IRF4 and SPI1 are co-expressed with IRF8. ChIPseq analysis indicates that SPI1 but not IRF4 binds to the promoter regions of Naips.
Therefore, it is also possible that SPI1 could function with IRF8 to regulate gene
expression of Naips and NLRC4 inflammasome activation. Whether IRF8 and SPI1 share
common binding sites for Naips needs to be explored.
Physiological Relevance of Differential Expression of Naips
The basally lower expression of Naip genes in IRF8-deficient mice resulted in
defective activation of the NLRC4 inflammasome. Irf8–/– mice infected with S.
Typhimurium or B. thailandensis had reduced gene expression of Naips in the spleen and
lungs, which contain heterogeneous populations of cells. Macrophages are not the only
cells to undergo NLRC4 inflammasome activation. NLRC4 inflammasome activation has
been shown in monocytes, dendritic cells, neutrophils, and lymphocytes 84–88. Thus,
inflammasome activation from many different cell types may contribute to NLRC4
inflammasome-mediated protection against bacterial pathogens.
We showed that IRF8-dependent expression of individual Naip genes varies
among tissues. The expression of Naip1, Naip5, Naip6, and Nlrc4, but not of Naip2, was
basally lower in the spleens of Irf8–/– mice than in those of WT mice. However, when we
analyzed gene expression in the lungs, there was a significant reduction in Naip2
expression as well as the other Naips. In certain cell types, other transcriptional factors
such as SPI1 may be more critical than IRF8. For instance, neutrophils do not express
IRF8 but nevertheless express NAIP and are able to activate the NLRC4
inflammasome86,89. It will be important to assess how IRF8 and SPI1 expression relates to
NAIP expression and NLRC4 inflammasome activation in different tissues and cell types.
In addition, different bacterial species produce variable amounts of single or multiple
NAIP ligands of varying affinity. The relative expression of Naips that would be able to
detect those ligands would also differ among heterogenous cell types. This combination
of host factors and pathogen factors may produce an astonishing degree of complexity in
NLRC4 inflammasome activation in vivo.
It is interesting that transcription of Naips was dependent on IRF8, but there was
no significant induction of Naips in vitro and in vivo in response to infection. We
observed that IRF8 expression in the spleens of S. Typhimurium–infected mice was
downregulated compared to that in the spleens of uninfected mice. This suggests that a
negative-feedback mechanism may restrict overt inflammasome activation during
persistent infection. Altogether, our work on IRF8 provides new insights into the
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regulation of the NAIP/NLRC4 inflammasome. The relationship among IRFs, the IFN
signaling pathway, and inflammasomes remains to be further explored.
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